Analyst firms · H.C. Wainwright · ABEO

H.C. Wainwright ABEO price target and rating history

Abeona Therapeutics Inc. (ABEO) · Health Care

H.C. Wainwright rates Abeona Therapeutics Inc. (ABEO) Buy with a $15 price target, as of its latest action on Jul 3, 2024. It has published 3 rating actions on ABEO since July 2021, including 0 upgrades and 0 downgrades.

Current rating
Buy
Price target
$15
Median target, all firms
Too few
Actions on ABEO
3

H.C. Wainwright price target on ABEO

$15$9.50$420222023202420252026
H.C. Wainwright price target on ABEO, each point a stated target, July 2021 to July 2024.

Every H.C. Wainwright rating on ABEO

Questions about H.C. Wainwright and ABEO

What is H.C. Wainwright's price target for ABEO?
H.C. Wainwright's latest stated price target for Abeona Therapeutics Inc. (ABEO) is $15, from its action on Jul 3, 2024.
What is H.C. Wainwright's rating on ABEO?
H.C. Wainwright rates ABEO Buy, a bullish rating, as of Jul 3, 2024.
When did H.C. Wainwright last change its view on ABEO?
On Jul 3, 2024, H.C. Wainwright starts coverage at Buy, price target $15.

All H.C. Wainwright ratingsABEO news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.